Overview

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Status:
Recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare in the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients.
Phase:
Phase 3
Details
Lead Sponsor:
Italfarmaco
Treatments:
Givinostat hydrochloride
Hydroxyurea